[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections].
Iakovlev
V P
VP
A.V. Vishnevsky Institute of Surgery, Russian Academy of Medical Sciences, Moscow.
Khlebnikov
E P
EP
Pavlova
M B
MB
Garanina
T A
TA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D017291:Clarithromycin / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010612:Pharyngitis / Q000150:complications / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014069:Tonsillitis / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D017291:Clarithromycin
Makrolidnyĭ antibiotik klaritromitsin (Klabaks) pri lechenii bronkholegochnykh infektsiĭ.